micro molecular dynamics simulation method Search Results


microarray business  (Molecular Dynamics Inc)
86
Molecular Dynamics Inc microarray business
Microarray Business, supplied by Molecular Dynamics Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/micro+molecular+dynamics+simulation+method/sec_filing____1741687_slash_000119312522168436_slash_d324661dpartiiandiii-795-10-14?v=Molecular+Dynamics+Inc
Average 86 stars, based on 1 article reviews
microarray business - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier
nitropure nitrocellulose transfer membranes  (Micron Separations Inc)
90
Micron Separations Inc nitropure nitrocellulose transfer membranes
Nitropure Nitrocellulose Transfer Membranes, supplied by Micron Separations Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/micro+molecular+dynamics+simulation+method/pm14523052-75-187-206?v=Micron+Separations+Inc
Average 90 stars, based on 1 article reviews
nitropure nitrocellulose transfer membranes - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
gen iii microarray laser scanner  (Molecular Dynamics Inc)
86
Molecular Dynamics Inc gen iii microarray laser scanner
Fig. 4. Relationship between regulated target genes and the relative drug peroxisome proliferator-acti- vated receptor- (PPAR-) efficacy. A: Comparison of quantitative expression levels as measured in microar- rays and Northern blot analysis and the relative PPAR- efficacies of the tested compounds using linear regres- sion analysis. Fold regulations as calculated in Table 2 were used for the <t>microarray</t> data, whereas signal in- tensities for the genes in Northern blots were col- lected using a PhosphorImager and normalized to the signals for ribosomal phosphoprotein 36B4. For apoli- poprotein <t>C-III</t> (apoC-III), the log fold change was used because this gene is downregulated and its ex- pression ratios lie between 1 and 0. B: Northern blots showing the expression of peroxisomal enoyl-CoA:hy- drotase-3-hydroxyacyl-CoA bifunctional enzyme (bi- functional enzyme), apoC-III, and ribosomal phos- phoprotein 36B4.
Gen Iii Microarray Laser Scanner, supplied by Molecular Dynamics Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/micro+molecular+dynamics+simulation+method/10__1194_slash_jlr__d300239___jlr200-70-6-11?v=Molecular+Dynamics+Inc
Average 86 stars, based on 1 article reviews
gen iii microarray laser scanner - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier
micro nano scale interface engineering grafting nano sio2 particles  (Molecular Dynamics Inc)
86
Molecular Dynamics Inc micro nano scale interface engineering grafting nano sio2 particles
Fig. 4. Relationship between regulated target genes and the relative drug peroxisome proliferator-acti- vated receptor- (PPAR-) efficacy. A: Comparison of quantitative expression levels as measured in microar- rays and Northern blot analysis and the relative PPAR- efficacies of the tested compounds using linear regres- sion analysis. Fold regulations as calculated in Table 2 were used for the <t>microarray</t> data, whereas signal in- tensities for the genes in Northern blots were col- lected using a PhosphorImager and normalized to the signals for ribosomal phosphoprotein 36B4. For apoli- poprotein <t>C-III</t> (apoC-III), the log fold change was used because this gene is downregulated and its ex- pression ratios lie between 1 and 0. B: Northern blots showing the expression of peroxisomal enoyl-CoA:hy- drotase-3-hydroxyacyl-CoA bifunctional enzyme (bi- functional enzyme), apoC-III, and ribosomal phos- phoprotein 36B4.
Micro Nano Scale Interface Engineering Grafting Nano Sio2 Particles, supplied by Molecular Dynamics Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/micro+molecular+dynamics+simulation+method/pm41597937-306-27-94?v=Molecular+Dynamics+Inc
Average 86 stars, based on 1 article reviews
micro nano scale interface engineering grafting nano sio2 particles - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier
dna microarrays  (Molecular Dynamics Inc)
86
Molecular Dynamics Inc dna microarrays
Fig. 4. Relationship between regulated target genes and the relative drug peroxisome proliferator-acti- vated receptor- (PPAR-) efficacy. A: Comparison of quantitative expression levels as measured in microar- rays and Northern blot analysis and the relative PPAR- efficacies of the tested compounds using linear regres- sion analysis. Fold regulations as calculated in Table 2 were used for the <t>microarray</t> data, whereas signal in- tensities for the genes in Northern blots were col- lected using a PhosphorImager and normalized to the signals for ribosomal phosphoprotein 36B4. For apoli- poprotein <t>C-III</t> (apoC-III), the log fold change was used because this gene is downregulated and its ex- pression ratios lie between 1 and 0. B: Northern blots showing the expression of peroxisomal enoyl-CoA:hy- drotase-3-hydroxyacyl-CoA bifunctional enzyme (bi- functional enzyme), apoC-III, and ribosomal phos- phoprotein 36B4.
Dna Microarrays, supplied by Molecular Dynamics Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/micro+molecular+dynamics+simulation+method/pm20423484-704-27-18?v=Molecular+Dynamics+Inc
Average 86 stars, based on 1 article reviews
dna microarrays - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier
gen iii microarray spotter  (Molecular Dynamics Inc)
86
Molecular Dynamics Inc gen iii microarray spotter
Fig. 4. Relationship between regulated target genes and the relative drug peroxisome proliferator-acti- vated receptor- (PPAR-) efficacy. A: Comparison of quantitative expression levels as measured in microar- rays and Northern blot analysis and the relative PPAR- efficacies of the tested compounds using linear regres- sion analysis. Fold regulations as calculated in Table 2 were used for the <t>microarray</t> data, whereas signal in- tensities for the genes in Northern blots were col- lected using a PhosphorImager and normalized to the signals for ribosomal phosphoprotein 36B4. For apoli- poprotein <t>C-III</t> (apoC-III), the log fold change was used because this gene is downregulated and its ex- pression ratios lie between 1 and 0. B: Northern blots showing the expression of peroxisomal enoyl-CoA:hy- drotase-3-hydroxyacyl-CoA bifunctional enzyme (bi- functional enzyme), apoC-III, and ribosomal phos- phoprotein 36B4.
Gen Iii Microarray Spotter, supplied by Molecular Dynamics Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/micro+molecular+dynamics+simulation+method/10__1194_slash_jlr__d300239___jlr200-63-40-38?v=Molecular+Dynamics+Inc
Average 86 stars, based on 1 article reviews
gen iii microarray spotter - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier
mems micro electromechanical systems nems nano  (Molecular Dynamics Inc)
86
Molecular Dynamics Inc mems micro electromechanical systems nems nano
Fig. 4. Relationship between regulated target genes and the relative drug peroxisome proliferator-acti- vated receptor- (PPAR-) efficacy. A: Comparison of quantitative expression levels as measured in microar- rays and Northern blot analysis and the relative PPAR- efficacies of the tested compounds using linear regres- sion analysis. Fold regulations as calculated in Table 2 were used for the <t>microarray</t> data, whereas signal in- tensities for the genes in Northern blots were col- lected using a PhosphorImager and normalized to the signals for ribosomal phosphoprotein 36B4. For apoli- poprotein <t>C-III</t> (apoC-III), the log fold change was used because this gene is downregulated and its ex- pression ratios lie between 1 and 0. B: Northern blots showing the expression of peroxisomal enoyl-CoA:hy- drotase-3-hydroxyacyl-CoA bifunctional enzyme (bi- functional enzyme), apoC-III, and ribosomal phos- phoprotein 36B4.
Mems Micro Electromechanical Systems Nems Nano, supplied by Molecular Dynamics Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/micro+molecular+dynamics+simulation+method/pm41900045-365-9-20?v=Molecular+Dynamics+Inc
Average 86 stars, based on 1 article reviews
mems micro electromechanical systems nems nano - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier
protein 1 micro ct microcomputed tomography md molecular dynamics nrf2 nuclear factor erythroid 2 related factor 2 nqo1  (Molecular Dynamics Inc)
86
Molecular Dynamics Inc protein 1 micro ct microcomputed tomography md molecular dynamics nrf2 nuclear factor erythroid 2 related factor 2 nqo1
Fig. 4. Relationship between regulated target genes and the relative drug peroxisome proliferator-acti- vated receptor- (PPAR-) efficacy. A: Comparison of quantitative expression levels as measured in microar- rays and Northern blot analysis and the relative PPAR- efficacies of the tested compounds using linear regres- sion analysis. Fold regulations as calculated in Table 2 were used for the <t>microarray</t> data, whereas signal in- tensities for the genes in Northern blots were col- lected using a PhosphorImager and normalized to the signals for ribosomal phosphoprotein 36B4. For apoli- poprotein <t>C-III</t> (apoC-III), the log fold change was used because this gene is downregulated and its ex- pression ratios lie between 1 and 0. B: Northern blots showing the expression of peroxisomal enoyl-CoA:hy- drotase-3-hydroxyacyl-CoA bifunctional enzyme (bi- functional enzyme), apoC-III, and ribosomal phos- phoprotein 36B4.
Protein 1 Micro Ct Microcomputed Tomography Md Molecular Dynamics Nrf2 Nuclear Factor Erythroid 2 Related Factor 2 Nqo1, supplied by Molecular Dynamics Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/micro+molecular+dynamics+simulation+method/pm42035997-32-75-82?v=Molecular+Dynamics+Inc
Average 86 stars, based on 1 article reviews
protein 1 micro ct microcomputed tomography md molecular dynamics nrf2 nuclear factor erythroid 2 related factor 2 nqo1 - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier
micro prodicon  (Molecular Dynamics Inc)
86
Molecular Dynamics Inc micro prodicon
Fig. 4. Relationship between regulated target genes and the relative drug peroxisome proliferator-acti- vated receptor- (PPAR-) efficacy. A: Comparison of quantitative expression levels as measured in microar- rays and Northern blot analysis and the relative PPAR- efficacies of the tested compounds using linear regres- sion analysis. Fold regulations as calculated in Table 2 were used for the <t>microarray</t> data, whereas signal in- tensities for the genes in Northern blots were col- lected using a PhosphorImager and normalized to the signals for ribosomal phosphoprotein 36B4. For apoli- poprotein <t>C-III</t> (apoC-III), the log fold change was used because this gene is downregulated and its ex- pression ratios lie between 1 and 0. B: Northern blots showing the expression of peroxisomal enoyl-CoA:hy- drotase-3-hydroxyacyl-CoA bifunctional enzyme (bi- functional enzyme), apoC-III, and ribosomal phos- phoprotein 36B4.
Micro Prodicon, supplied by Molecular Dynamics Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/micro+molecular+dynamics+simulation+method/pm02822087-49-10-11?v=Molecular+Dynamics+Inc
Average 86 stars, based on 1 article reviews
micro prodicon - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier
microcal peaq itc analysis software  (Malvern Panalytical)
99
Malvern Panalytical microcal peaq itc analysis software
Fig. 4. Relationship between regulated target genes and the relative drug peroxisome proliferator-acti- vated receptor- (PPAR-) efficacy. A: Comparison of quantitative expression levels as measured in microar- rays and Northern blot analysis and the relative PPAR- efficacies of the tested compounds using linear regres- sion analysis. Fold regulations as calculated in Table 2 were used for the <t>microarray</t> data, whereas signal in- tensities for the genes in Northern blots were col- lected using a PhosphorImager and normalized to the signals for ribosomal phosphoprotein 36B4. For apoli- poprotein <t>C-III</t> (apoC-III), the log fold change was used because this gene is downregulated and its ex- pression ratios lie between 1 and 0. B: Northern blots showing the expression of peroxisomal enoyl-CoA:hy- drotase-3-hydroxyacyl-CoA bifunctional enzyme (bi- functional enzyme), apoC-III, and ribosomal phos- phoprotein 36B4.
Microcal Peaq Itc Analysis Software, supplied by Malvern Panalytical, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/micro+molecular+dynamics+simulation+method/pm35332294-516-71-71?v=Malvern+Panalytical
Average 99 stars, based on 1 article reviews
microcal peaq itc analysis software - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

Image Search Results


Fig. 4. Relationship between regulated target genes and the relative drug peroxisome proliferator-acti- vated receptor- (PPAR-) efficacy. A: Comparison of quantitative expression levels as measured in microar- rays and Northern blot analysis and the relative PPAR- efficacies of the tested compounds using linear regres- sion analysis. Fold regulations as calculated in Table 2 were used for the microarray data, whereas signal in- tensities for the genes in Northern blots were col- lected using a PhosphorImager and normalized to the signals for ribosomal phosphoprotein 36B4. For apoli- poprotein C-III (apoC-III), the log fold change was used because this gene is downregulated and its ex- pression ratios lie between 1 and 0. B: Northern blots showing the expression of peroxisomal enoyl-CoA:hy- drotase-3-hydroxyacyl-CoA bifunctional enzyme (bi- functional enzyme), apoC-III, and ribosomal phos- phoprotein 36B4.

Journal: The Journal of Lipid Research

Article Title: Prediction of PPAR- ligand-mediated physiological changes using gene expression profiles

doi: 10.1194/jlr.d300239-jlr200

Figure Lengend Snippet: Fig. 4. Relationship between regulated target genes and the relative drug peroxisome proliferator-acti- vated receptor- (PPAR-) efficacy. A: Comparison of quantitative expression levels as measured in microar- rays and Northern blot analysis and the relative PPAR- efficacies of the tested compounds using linear regres- sion analysis. Fold regulations as calculated in Table 2 were used for the microarray data, whereas signal in- tensities for the genes in Northern blots were col- lected using a PhosphorImager and normalized to the signals for ribosomal phosphoprotein 36B4. For apoli- poprotein C-III (apoC-III), the log fold change was used because this gene is downregulated and its ex- pression ratios lie between 1 and 0. B: Northern blots showing the expression of peroxisomal enoyl-CoA:hy- drotase-3-hydroxyacyl-CoA bifunctional enzyme (bi- functional enzyme), apoC-III, and ribosomal phos- phoprotein 36B4.

Article Snippet: The slide was scanned in a Gen. III microarray laser scanner (Molecular Dynamics).

Techniques: Comparison, Expressing, Northern Blot, Microarray, Functional Assay

Fig. 4. Relationship between regulated target genes and the relative drug peroxisome proliferator-acti- vated receptor- (PPAR-) efficacy. A: Comparison of quantitative expression levels as measured in microar- rays and Northern blot analysis and the relative PPAR- efficacies of the tested compounds using linear regres- sion analysis. Fold regulations as calculated in Table 2 were used for the microarray data, whereas signal in- tensities for the genes in Northern blots were col- lected using a PhosphorImager and normalized to the signals for ribosomal phosphoprotein 36B4. For apoli- poprotein C-III (apoC-III), the log fold change was used because this gene is downregulated and its ex- pression ratios lie between 1 and 0. B: Northern blots showing the expression of peroxisomal enoyl-CoA:hy- drotase-3-hydroxyacyl-CoA bifunctional enzyme (bi- functional enzyme), apoC-III, and ribosomal phos- phoprotein 36B4.

Journal: The Journal of Lipid Research

Article Title: Prediction of PPAR- ligand-mediated physiological changes using gene expression profiles

doi: 10.1194/jlr.d300239-jlr200

Figure Lengend Snippet: Fig. 4. Relationship between regulated target genes and the relative drug peroxisome proliferator-acti- vated receptor- (PPAR-) efficacy. A: Comparison of quantitative expression levels as measured in microar- rays and Northern blot analysis and the relative PPAR- efficacies of the tested compounds using linear regres- sion analysis. Fold regulations as calculated in Table 2 were used for the microarray data, whereas signal in- tensities for the genes in Northern blots were col- lected using a PhosphorImager and normalized to the signals for ribosomal phosphoprotein 36B4. For apoli- poprotein C-III (apoC-III), the log fold change was used because this gene is downregulated and its ex- pression ratios lie between 1 and 0. B: Northern blots showing the expression of peroxisomal enoyl-CoA:hy- drotase-3-hydroxyacyl-CoA bifunctional enzyme (bi- functional enzyme), apoC-III, and ribosomal phos- phoprotein 36B4.

Article Snippet: The purified PCR products were mixed 1:1 in DMSO (Sigma, St. Louis, MO) and rearranged in 384-well plates. cDNA targets were spotted in duplicate onto silanized glass slides (Amersham Biosciences, Buckinghamshire, UK) at 55% relative humidity using the Molecular Dynamics Gen. III microarray spotter.

Techniques: Comparison, Expressing, Northern Blot, Microarray, Functional Assay